A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 20, 2019

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Coronary Artery Disease
Interventions
DRUG

Treatment A

Subject will be given AZD5718 Dose A tablet once daily

DRUG

Treatment B

Subjects will be given AZD5718 Dose B tablet once daily

DRUG

Treatment C

Subjects will be given AZD5718 Dose C tablet once daily

Trial Locations (1)

HA1 3UJ

Research Site, London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Parexel

INDUSTRY

lead

AstraZeneca

INDUSTRY